The ratings agency has affirmed BBB ratings for Thermo Fisher's long term issuer default rating, senior notes, and bank revolving credit facility.
The ratings firm noted Thermo Fisher's efforts to bring down its debt and said that the company could resume bolt-on acquisitions next year.
The story has been updated with information about the pricing of the notes released by Agilent after the close of the market.
NEW YORK (GenomeWeb News) – Standard & Poor's on Thursday raised Life Technologies' corporate credit rating and the issue-level rating on the firm's secured and unsecured debt to BBB+.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Fitch Ratings late on Tuesday affirmed several ratings of BBB+ for Agilent Technologies.
Morningstar said that the rating reflects its negative view of the genetic analysis instrument business and potential competitive pressure for Illumina.
The rating agency raised its outlook on Agilent to 'positive' from 'stable' due to "greater confidence in Agilent's operating and financial profile."
S&P cited Bio-Rad's "solid operating performance and cash flow generation" in announcing the upgrade.
A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.
A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.
In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.
A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.